A new version of the McDonald criteria — the official guidelines used to diagnose MS — aim to make MS diagnosis faster and ...

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

Columnist Ben Hofmeister worries about his MS cognitive symptoms worsening and wonders if he'll even be aware of the changes.

Columnist Desiree Lama struggles to effectively manage stress, but given her multiple sclerosis, learning to do so is vital, ...

Fasting and ketogenic diets were found to benefit blood fats, weight, and blood pressure in MS, but did not reduce brain ...

Children who go on to develop pediatric-onset MS have more emergency department visits than their peers, starting years ...

Understanding how MS can impact your income, insurance, disability benefits, and budgeting allows you to plan ahead with ...

Paramagnetic rim lesions, or areas of damage in the brain and spinal cord, could be a useful tool for diagnosing MS, a study ...

A generic formulation of Zeposia will be manufactured and supplied by Netherlands-based Synthon, upon final approval by the ...

As cold and flu season approaches, columnist Leigh Anne Nelson shares her experience getting vaccinated against the flu and pneumonia.

Immunic Therapeutics will receive a new U.S. patent covering its experimental therapy, vidofludimus calcium, and some related molecules in people with multiple sclerosis (MS). It’s expected to provide ...